- 积分
- 362683
好友
记录
日志
相册
回帖0
主题
分享
精华
威望 旺
钢镚 分
推荐 人
|
注册后推荐绑定QQ,之后方才可以使用下方的“用QQ帐号登录”。
您需要 登录 才可以下载或查看,没有账号?立即注册
x
Editorial Reviews + R* U3 H, _ X/ d( w: }. ]) E. f) z
* R3 N5 l* v! a; X
Product Details
/ u, p" W, Q! X: v2 T2 pPaperback: 464 pages
/ F8 J: G, s6 J' \# F' ~Publisher: SAS Publishing; 1 edition (February 26, 2007) & c `9 J! |+ `( r) K
Language: English 2 E& O+ L2 k7 j9 T% T6 c
ISBN-10: 159047886X
3 T d/ C$ f* m6 X+ l5 [5 JISBN-13: 978-1590478868 4 x& o+ x1 s( Z/ k
Product Dimensions: 10.8 x 8.4 x 0.5 inches
% n$ n$ [( d1 }
9 G* w+ c% G) f x: {
/ @( g- b' y/ ~- H5 b7 t* JReview
. d+ ?* b; q" p6 o- u"Pharmaceutical Statistics Using SAS contains applications of cutting-edge statistical techniques using cutting-edge software tools provided by SAS. The theory is presented in down-to-earth ways, with copious examples, for simple understanding. For pharmaceutical statisticians, connections with appropriate guidance documents are made; the connections between the document and the data analysis techniques make 'standard practice' easy to implement. In addition, the included references make it easy to find these guidance documents that are often obscure. Specialized procedures, such as easy calculation of the power of nonparametric and survival analysis tests, are made transparent, and this should be a delight to the statistician working in the pharmaceutical industry, who typically spends long hours on such calculations. However, non-pharmaceutical statisticians and scientists will also appreciate the treatment of problems that are more generally common, such as how to handle dropouts and missing values, assessing reliability and validity of psychometric scales, and decision theory in experimental design. I heartily recommend this book to all." --Peter H. Westfall, Professor of Statistics, Texas Tech University / V4 _2 _& {$ C. g
. q: v/ e" o; i$ w4 S8 s"The book should be a very useful guide for practicing statisticians. What impressed me most was its breadth; it covers all stages of drug development, from preclinical testing to early clinical studies and late-stage clinical studies. The editors have pulled together an excellent set of authors, including experts from the pharmaceutical industry and prominent academics." --Steve Snapinn, Executive Director, Clinical Development Biostatistics Amgen, Inc. ' n5 A8 z3 T" W7 b( [
9 h1 A& x9 H% ~$ C, F8 e"This book is an ideal overview of some of the many important issues arising in the pharmaceutical industry, and can be read as such. Students anticipating a career in pharmaceutical statistics will benefit particularly: these are topics that form the backbone of statistics in the industry but that are not generally taught as part of an M.S. or Ph.D. program. Implementation using SAS is admirably detailed, but even non-users of SAS will find the book useful." --Raymond J. Carroll, Distinguished Professor of Statistics, Nutrition and Toxicology, Texas A&M University . x e: c. g! B8 f5 W
6 u$ ?! [" D" w3 \Product Description
6 @& ]% w4 y8 R3 b" RThis essential new book offers extensive coverage of cutting-edge biostatistical methodology used in drug development and the practical problems facing today's drug developers. Written by well-known experts in the pharmaceutical industry, it provides relevant tutorial material and SAS examples to help readers new to a certain area of drug development quickly understand and learn popular data analysis methods and apply them to real-life problems. Step-by-step, the book introduces a wide range of data analysis problems encountered in drug development and illustrates them using a wealth of case studies from actual pre-clinical experiments and clinical studies. The book also provides SAS code for solving the problems. Among the topics addressed are these: drug discovery experiments to identify promising chemical compounds ! z9 L# R$ T3 S' ^' d# f) G( J1 O% \
animal studies to assess the toxicological profile of these compounds
b. n8 W8 r* z4 x9 iclinical pharmacology studies to examine the properties of new drugs in healthy human subjects 7 }3 A1 {$ o/ k/ }. |8 {, W
Phase II and Phase III clinical trials to establish therapeutic benefits of experimental drugs 7 \; g% N& d- \
Additional features include a discussion of methodological issues, practical advice from subject-matter experts, and review of relevant regulatory guidelines. Most chapters are self-contained and include a fair amount of high-level introductory material to make them accessible to a broad audience of pharmaceutical scientists. This book will also serve as a useful reference for regulatory scientists as well as academic researchers and graduate students. |
-
-
-
Pharmaceutical Statistics Using SAS.part4.rar
150.65 KB, 下载次数: 18, 下载积分: 钢镚 -1 分, 参与 1 贴
-
-
Pharmaceutical Statistics Using SAS.part2.rar
1000 KB, 下载次数: 13, 下载积分: 钢镚 -1 分, 参与 1 贴
-
-
Pharmaceutical Statistics Using SAS.part3.rar
1000 KB, 下载次数: 13, 下载积分: 钢镚 -1 分, 参与 1 贴
-
-
Pharmaceutical Statistics Using SAS.part1.rar
1000 KB, 下载次数: 15, 下载积分: 钢镚 -1 分, 参与 1 贴
|